In the homologous challenge model, IgGs from DENV2-immune WT mice provided protection against DENV2 infection, resulting in reduced viral titers compared with the IgGs from naive or CD1d-KO infection groups (Figure 8F). This evidence concerns the gene CD1D and infection.